Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
about
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerPersistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisCervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theCervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa.Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.Cervical cytological abnormalities and HPV infection in perinatally HIV-infected adolescents.Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western KenyaHigh-grade cervical disease in adolescents with HIVSunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skinThirty years later: pregnancies in females perinatally infected with human immunodeficiency virus-1.Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected childrenHuman papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso.Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology.Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings.Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria.Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya.Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis.High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.Pregnancy care in two adolescents perinatally infected with HIVRisk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the F
P2860
Q33650105-200FCC40-E27E-4B4E-8DA7-BCA8A77200A1Q33883532-E5855FD6-9359-4FCF-9EDE-FCEA622867DEQ34124803-934FD3E0-6A20-49E6-97A2-017375E9A798Q34146342-B7E3EE73-E4F2-4798-930F-E73375DD2FE1Q34212799-B65CC6D3-07EE-406A-A750-F61AF395AEC3Q34441738-8570D8BD-0190-4A58-9DF9-9DE01C547522Q34549645-2839E51D-BAAB-4C2F-9B09-3318CF137816Q35186321-47CF8E4C-1363-46A7-9671-C353AB67780BQ35628713-C1F921D9-F8FC-452B-8109-DCB3024F18F2Q35788402-1A642285-1D50-45C2-BB45-39EEFD6DA45FQ35866450-BBA4F921-E279-4829-A20E-C18D99EFA4D4Q35974346-24A34421-235F-44D9-91CC-18D9F9CD2F37Q36210517-4B69B24E-B0ED-48C9-AA1A-13FC0AFF3433Q36319582-27760F1C-5B90-490D-B0DB-607E4DEAF554Q36417513-274CB31A-6F68-4735-BE54-9FC70DACCCF9Q36486823-9FA76736-8860-482C-9084-4EFCF0A97E9EQ36612102-F990C48D-BC11-4466-BB97-66F1D56CC8BEQ36615509-C7960741-EB6F-4CB4-82D2-4C8395083F83Q37028187-1FD63DC2-7AC4-4E15-855D-5FD8540B289BQ37034968-0AF1E160-7E34-4EE0-8C44-249283F7341FQ37412919-FDDFE21E-3559-45E6-8FC4-ED96FDC67CB8Q38154009-2A59DCDA-4804-4CF1-A0C4-D332190B5534Q45326416-EF91785A-C313-4E77-B75D-B6015499A713Q46335294-88BCC927-F08D-49A0-B456-5B8D4947278FQ47548955-4A240731-C31C-432C-A49B-658BDA860337Q49900329-A362F481-5070-4DE3-8451-4BE0692DD5ECQ58128607-1D22727C-505F-4226-AEB7-13CBF1A2AC79Q58850470-9DD85F95-0DA6-4A44-B9DD-7489D4FE3A03
P2860
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
@ast
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
@en
type
label
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
@ast
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
@en
prefLabel
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
@ast
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
@en
P2093
P356
P1476
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.
@en
P2093
Anna-Barbara Moscicki
Jiahong Xu
Jonas H Ellenberg
Peggy Crowley-Nowick
Sepidah Fahrat
Teresa M Darragh
P304
P356
10.1086/424466
P407
P577
2004-09-13T00:00:00Z